Here are five notes:
1. The analysts have an “outperform” rating on Surgery Partners’ shares.
2. RBC Capital’s price target indicates a potential upside of 25 percent from Surgery Partners’ previous close.
3. Surgery Partners has a 12-month high of $22.32 and 12-month low of $11.97.
4. The company has a market cap of $770.50 million.
5. For the fourth quarter, Surgery Partners had an EPS of $0.35.
For more on Surgery Partners’ fourth quarter results, click here.
More articles on surgery centers:
Children’s Hospital of Richmond at VCU to open outpatient pavilion: 4 notes
OhioHealth to expand outpatient services: 4 things to know
4 key points on DuPage Medical Group acquiring Midwest ENT Consultants
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
